In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil

Mycopathologia

Volumn 161, Issue 1, 2006, Pages 21-26

  Cordeiro, R A ^a,b   Brilhante, R S N ^a,b   Rocha, M F G ^a,b   Fechine, M A B ^a   Costa, A K F ^a   Camargo, Z P ^c   Sidrim, J J C ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antifungal susceptibility testing; Coccidioides posadasii; Northeast Brazil

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; CYCLOPEPTIDE; PYRROLE DERIVATIVE;

ARTICLE; BRAZIL; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; AZOLES; BRAZIL; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC;

COCCIDIOIDES; COCCIDIOIDES POSADASII; FUNGI;

EID: 29944439982     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-005-0177-0     Document Type: Article

References (25)

1. RF Hector R. Laniado-Laborin 2005 Coccidioidomycosis - a fungal disease of the Americas PLoS Med 2 15 18
2. MC Fisher GL Koenig TJ White JW. Taylor 2002 Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis Mycologia 94 73 84
3. OM Gomes RRP Serrano HOV Pradel NLTB Moraes ALB Varella AI. Fiorelli 1978 Coccidioidomicose pulmonar. Primeiro caso nacional Rev Assoc Med Bras 24 167 168
4. JJC LCI JMA Sidrim Silva Nunes MFG Rocha GC. Paixão 1997 Le nord-est brésilien, région dendémie de coccidioidomycose? A propos dune micro-épidémie J Mycol Méd 7 37 39
5. Paixão GC, Rocha MFG, Sidrim JJC. Coccidioidomicose e blastomicose. In: Sidrim JJC, Rocha MFG, eds. Micologia médica à luz de autores contemporâneos, Editora Guanabara Koogan, Rio de Janeiro, 2004: 237-251
6. R Bialek J Kern T Herrmann R Tijerina L Ceceñas U Reischl GM. González 2004 PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/proline-rich antigen J Clin Microbiol 42 778 783
7. L Louie S Ng R Hajjeh R Johnson D Vugia SB Werner R Talbot W. Klitz 1999 Influence of host genetics on the severity of coccidioidomycosis Emerg Infect Dis 5 672 680
8. JE Blair JL Logan 2001 Coccidioidomycosis in solid organ transplantation Clin Infect Dis 33 1536 1544
9. NM. Ampel 2004 Combating opportunistic infections: coccidioidomycosis Expert Opin Pharmacother 5 255 261
10. JN Galgiani NM Ampel A Catanzaro RH Johnson DA Stevens PL. Williams 2000 Practice guideline for the treatment of coccidioidomycosis Clin Infect Dis 30 658 661
11. SC Deresinski 2001 Coccidioidomycosis: efficacy of new agents and future prospects Curr Opin Infect Dis 14 693 696
12. RM Prabhu M Bonnell BL Currier R Orenstein 2004 Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole Clin Infect Dis 39 74 77
13. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; approved standard, M38-A, vol. 18 no. 3. National Committee for Clinical Laboratory Standards, Wayne, 2002
14. GM González R Tijerina LK Najvar R Bocanegra MG Rinaldi JR Graybill 2001 Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model Antimicrob Agents Chemother 45 1854 1859
15. T Nakai J Uno F Ikeda S Tawara K Nishimura M Miyaji 2003 In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms Antimicrob Agents Chemother 47 1376 1381
16. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, 1997
17. AL Barry MA Pfaller SD Brown A Espinel-Ingroff MA Ghannoum C Knapp RP Rennie JH Rex MG Rinaldi 2000 Quality control limits for broth microdilution susceptibility tests of ten antifungal agents J Clin Microbiol 38 3457 3459
18. LA Proia AR Tenorio 2004 Successful use of voriconazole for treatment of Coccidioides meningitis Antimicrob Agents Chemother 48 2341
19. GM González R Tijerina LK Najvar R Bocanegra M Rinaldi D Loebenberg JR Graybill 2002 In vitro and in vivo activities of posaconazole against Coccidioides immitis Antimicrob Agents Chemother 46 1352 1356
20. Ministério da Saúde. Coccidioidomicose. In: Doenças infecciosas e parasitárias: guia de bolso, Ministério da Saúde, Brasília, Brasil, 2004; 72-74
21. V Valérie Letscher-Bru R Herbrecht 2003 Caspofungin: the first representative of a new antifungal class J Antimicrob Chemother 51 513 521
22. RK Li MA Ciblak N Nordoff L Pasarell DW Warnock MR McGinnis 2000 In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum Antimicrob Agents Chemother 44 1734 1736
23. JE Lutz KV Clemons BH Aristizabal DA Stevens 1997 Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis Antimicrob Agents Chemother 41 1558 1561
24. PD Hoeprich JM. Merry 1984 In vitro activities of two new antifungal azoles Antimicrob Agents Chemother 25 339 341
25. D Pappagianis BL Zimmer G Theodoropoulos M Plempel RF Hector 1990 Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis Antimicrob Agents Chemother 34 1132 1138